Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma

Publication date: September 2017
Source:European Journal of Cancer, Volume 83
Author(s): Selma Ugurel, Felix Kiecker, Stefan Fröhling, Axel Wetter, Agnes Bankfalvi, Antje Sucker, Lisa Zimmer, Elisabeth Livingstone, Alexander Roesch, Jürgen C. Becker, Dirk Schadendorf




http://ift.tt/2ubAWLa